Titelia

Holdings of Global X Genomics & Biotechnology ETF

GLOBAL X FUNDS · Original filing · Compare with another fund · Report an error

Net assets
55.8M $ including 55.7M $ in equities, 99.9 %
Positions
50 in 8 countries
Top ten
42.5 % of net assets
Filed on
May 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1GUARDANT HEALTH INC 24,0593.1M $5.59 %
2Illumina Inc 16,5122.7M $4.82 %
3NATERA INC 10,3702.3M $4.15 %
4BioMarin Pharmaceutical Inc 39,7922.3M $4.09 %
5Arrowhead Pharmaceuticals Inc 29,1502.3M $4.07 %
6LEGEND BIOTECH CORP 83,0992.3M $4.05 %
7Praxis Precision Medicines Inc 6,3882.2M $4.01 %
8TWIST BIOSCIENCE CORP 33,0872.2M $3.97 %
9Vertex Pharmaceuticals Inc 4,9232.2M $3.95 %
10CRISPR Therapeutics AG 38,1912.1M $3.85 %
11Veracyte Inc 43,8072M $3.64 %
12QIAGEN NV 53,9092M $3.54 %
13BioNTech SE 19,8411.9M $3.41 %
14Bio-Techne Corp 36,7831.9M $3.41 %
15MODERNA INC 38,7551.8M $3.28 %
1610X Genomics Inc 63,6651.8M $3.23 %
17Beam Therapeutics Inc 52,3061.7M $3.09 %
18Eli Lilly & Co 1,1691.3M $2.32 %
19Ultragenyx Pharmaceutical Inc 52,4261.3M $2.25 %
20CARIS LIFE SCIENCES INC 67,7481.1M $2.03 %
21Genscript Biotech Corp 638,8181.1M $2.00 %
22Billiontoone Inc 11,1211.1M $1.97 %
23Gilead Sciences Inc 8,1071.1M $1.95 %
24AstraZeneca PLC 5,4901M $1.83 %
25SAREPTA THERAPEUTICS INC 56,1331M $1.80 %
26uniQure NV 31,188889.8K $1.59 %
27Intellia Therapeutics Inc 63,134888.3K $1.59 %
28Stoke Therapeutics Inc 26,232810.8K $1.45 %
29GeneDx Holdings Corp 14,482752.9K $1.35 %
30Danaher Corp 3,573652.7K $1.17 %
31Bristol-Myers Squibb Co 11,273644.6K $1.16 %
32Vir Biotechnology Inc 64,900619.1K $1.11 %
33CareDx Inc 25,735587.3K $1.05 %
34WAVE LIFE SCIENCES LTD 87,259574.2K $1.03 %
35Personalis Inc 38,475438.6K $0.79 %
36Maravai LifeSciences Holdings Inc 58,810282.3K $0.51 %
37Bruker Corp 4,056238.9K $0.43 %
38Pacific Biosciences of California Inc 151,435225.6K $0.40 %
39Benitec Biopharma Inc 18,350212.1K $0.38 %
40Agilent Technologies Inc 1,553210.5K $0.38 %
41Fulgent Genetics Inc 11,030200.1K $0.36 %
42Standard BioTools Inc 170,786196.4K $0.35 %
43Myriad Genetics Inc 48,961194.4K $0.35 %
44Editas Medicine Inc 54,725189.3K $0.34 %
45PRIME MEDICINE INC 53,111188.5K $0.34 %
46REGENXBIO Inc 25,888181.5K $0.33 %
47Rocket Pharmaceuticals Inc 57,609176.9K $0.32 %
48Mesa Laboratories Inc 1,589162.1K $0.29 %
49Caribou Biosciences Inc 68,184160.9K $0.29 %
50Quest Diagnostics Inc 789153.8K $0.28 %

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Health care 25.3 %
  • Unattributed 74.7 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 96.2 %
  • HKD 2.0 %
  • GBP 1.8 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 82.2 %
  • Cayman Islands 4.0 %
  • Switzerland 3.8 %
  • Germany 3.4 %
  • Hong Kong SAR China 2.0 %
  • United Kingdom 1.8 %
  • Netherlands 1.6 %
  • Singapore 1.0 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States4345.8M $82.23 %
2Cayman Islands12.3M $4.05 %
3Switzerland12.1M $3.85 %
4Germany11.9M $3.42 %
5Hong Kong SAR China11.1M $2.00 %
6United Kingdom11M $1.83 %
7Netherlands1889.8K $1.60 %
8Singapore1574.2K $1.03 %
Cite this page

Titelia. "Holdings of Global X Genomics & Biotechnology ETF". https://titelia.com/en/funds/S000062676